Gene Editing Reduces Monkeys’ Cholesterol
Gene Editing Reduces Monkeys’ Cholesterol

Gene Editing Reduces Monkeys’ Cholesterol

The results could lead to a treatment to lower cholesterol in patients with hypercholesterolemia.

Ashley Yeager
Ashley Yeager

Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at...

View full profile.


Learn about our editorial policies.

Jul 10, 2018

Editing monkeys’ genomes in their livers reduced the animals’ blood cholesterol levels, researchers reported yesterday (July 9) in Nature Biotechnology. The results suggest the technique could one day be used to treat certain heart disease patients who do not tolerate drugs designed to combat high cholesterol. 

“It’s very nice work, one of the first demonstrations of gene-editing tools used with high efficiency in nonhuman primates,” Kiran Musunuru, a cardiologist and geneticist at the University of Pennsylvania who was not involved in the study, tells Science.

In the study, University of Pennsylvania gene therapy researcher James Wilson and his colleagues used a gene-editing tool called a meganuclease to target and inactivate the gene PCSK9, which produces a protein that prevents the body from removing LDL, the “bad” form of cholesterol, in the monkeys’ livers. The approach “worked incredibly well,” Wilson tells Science

PCSK9 levels dropped by...

“Most often these patients are treated with repeated injections of an antibody to PCSK9,” study coauthor Lili Wang says in a statement. “But, our study shows that with successful genome editing, patients who cannot tolerate inhibitor drugs might no longer need this type of repeat treatment.”

Many gene-editing tools are currently being tested, however, so “it’s too early to tell which of those approaches will translate” into people, MIT molecular geneticist Daniel Anderson tells Science.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?